Suchergebnisse - "Struyf, Frank"

PubPharm (143)

1

Multivalent vaccine compositions and uses thereof

enthalten in: Europäisches Patentamt | 2024

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

2

Multivalent vaccine compositions and uses thereof

enthalten in: Europäisches Patentamt | 2024

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

3

Risk of COVID-19 after natural infection or vaccination

enthalten in: EBioMedicine | 2023

von Rick, A. | Laurens, M. | Huang, Y. | +125

4

Thrombosis with thrombocytopenia syndrome : A database review of clinical trial and post-marketing experience with Ad26.COV2.S

enthalten in: Vaccine | 2023

von Struyf, F. | Hardt, K. | Van Rampelbergh, R. | +12

5

MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

6

MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

7

다가 백신 조성물 및 이의 용도

enthalten in: Europäisches Patentamt | 2023

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

8

다가 백신 조성물 및 이의 용도

enthalten in: Europäisches Patentamt | 2023

von POOLMAN JAN THEUNIS | FAE KELLEN CRISTHINA | SARNECKI MICHAL | +4

9

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults : Phase 1/2 Randomized Clinical Trial

enthalten in: The Journal of infectious diseases | 2023

von Leroux-Roels, I. | Davis, M. | Steenackers, K. | +19

10

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]